ECM
NVLN

Element Capital Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Element Capital Management’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-34,804
Closed -$103K – 1017
2018
Q3 		$103K Sell
34,804
-26,641
-43% -$94.3K ﹤0.01% 851
2018
Q2 		$226K Buy
+61,445
New +$247K 0.01% 671

Other funds holding NVLN

EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Element Capital Management's NVLN Position: Q4 2018 in Review

Element Capital Management sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q4 2018, closing a stake of 34,804 shares — an estimated $103K sold.

Element Capital Management first reported a position in NVLN in Q2 2018 and held it in 2 quarters. The position peaked at $226K in Q2 2018. 36 funds tracked by Wall St. Rank hold NVLN as of Q4 2018.

  • Element Capital Management reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q4 2018 after selling out during the quarter.
  • Element Capital Management sold 34,804 Novelion Therapeutics Inc. Common Shares shares in Q4 2018, an estimated $103K.
  • Element Capital Management first reported a position in Novelion Therapeutics Inc. Common Shares in Q2 2018 and held it in 2 quarters.
  • Element Capital Management's Novelion Therapeutics Inc. Common Shares position peaked at $226K in Q2 2018.
  • 36 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q4 2018.

Based on Element Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.